Lyngbyoic acid, a "tagged" fatty acid from a marine cyanobacterium, disrupts quorum sensing in Pseudomonas aeruginosa

Mol Biosyst. 2011 Apr;7(4):1205-16. doi: 10.1039/c0mb00180e. Epub 2011 Jan 24.

Abstract

Quorum sensing (QS) is a mechanism of bacterial gene regulation in response to increases in population density. Perhaps most studied are QS pathways mediated by acylhomoserine lactones (AHLs) in Gram-negative bacteria. Production of small molecule QS signals, their accumulation within a diffusion-limited environment and their binding to a LuxR-type receptor trigger QS-controlled gene regulatory cascades. In Pseudomonas aeruginosa, for example, binding of AHLs to their cognate receptors (LasR, RhlR) controls production of virulence factors, pigments, antibiotics and other behaviors important for its interactions with eukaryotic hosts and other bacteria. We have previously shown that marine cyanobacteria produce QS-inhibitory molecules, including 8-epi-malyngamide C (1), malyngamide C (2) and malyngolide (3). Here we isolated a new small cyclopropane-containing fatty acid, lyngbyoic acid (4), as a major metabolite of the marine cyanobacterium, Lyngbya cf. majuscula, collected at various sites in Florida. We screened 4 against four reporters based on different AHL receptors (LuxR, AhyR, TraR and LasR) and found that 4 most strongly affected LasR. We also show that 4 reduces pyocyanin and elastase (LasB) both on the protein and transcript level in wild-type P. aeruginosa, and that 4 directly inhibits LasB enzymatic activity. Conversely, dodecanoic acid (9) increased pyocyanin and LasB, demonstrating that the fused cyclopropane "tag" is functionally relevant and potentially confers resistance to β-oxidation. Global transcriptional effects of 4 in some ways replicate the gene expression changes of P. aeruginosa during chronic lung infections of cystic fibrosis patients, with reduced lasR signaling, increased biofilm and expression of the virulence locus HSI-I. Compound 4 may therefore prove to be a useful tool in the study of P. aeruginosa adaption during such chronic infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl-Butyrolactones / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / metabolism
  • Binding Sites
  • Cyanobacteria / chemistry*
  • Cyclopropanes / pharmacology*
  • Fatty Acids / chemistry
  • Fatty Acids / pharmacology*
  • Gene Expression Profiling
  • Gene Expression Regulation, Bacterial / drug effects
  • Gene Order
  • Genes, Reporter
  • Plasmids / genetics
  • Protein Binding
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / physiology*
  • Quorum Sensing / drug effects*
  • Trans-Activators / metabolism

Substances

  • Acyl-Butyrolactones
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Cyclopropanes
  • Fatty Acids
  • LasR protein, Pseudomonas aeruginosa
  • Trans-Activators
  • lyngbyoic acid